|
N- (3- {[α- D- GalNAc- (1→4)- α- D- GalNAc- (1→4)- α- D- GalNAc- yl]oxy}propyl)- 21- (biotinylamino)- 4,7,10,13,16,19- hexaoxadodecan- 1- amide |
|
CHEBI:146271 |
|
N- (3- {[alpha- D- GalNAc- (1- >4)- alpha- D- GalNAc- (1- >4)- alpha- D- GalNAc- yl]oxy}propyl)- 21- (biotinylamino)- 4,7,10,13,16,19- hexaoxadodecan- 1- amide |
|
A trisaccharide derivative in which N-acetyl-α-D-galactosaminyl-(1→4)-N-acetyl-α-D-galactosaminyl-(1→4)-N-acetyl-α-D-galactosamine is linked glycosidically to biotin via a (21-oxo-3,6,9,12,15,18-hexaoxa-22-azapentacosan-1-yl)amino spacer. One of a set of synthesised biotinylated oligo-α-(1→4)-D-galactosamines comprising from two to six monosaccharide units, along with their N-acetylated derivatives (PMID:31913631), aimed at analysing the specificity of the antibody responses to a complex exopolysaccharide galactosaminogalactan found in Aspergillus fumigatus, the most important airborne human fungal pathogen in industrialized countries. |
|
![](images/goldenstar.gif) ![](images/goldenstar.gif)
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C52H91N7O25S/c1- 29(63) 55- 40- 44(69) 43(68) 33(25- 60) 80- 50(40) 83- 48- 35(27- 62) 82- 51(42(46(48) 71) 57- 31(3) 65) 84- 47- 34(26- 61) 81- 49(41(45(47) 70) 56- 30(2) 64) 79- 12- 6- 10- 53- 38(67) 9- 13- 73- 15- 17- 75- 19- 21- 77- 23- 24- 78- 22- 20- 76- 18- 16- 74- 14- 11- 54- 37(66) 8- 5- 4- 7- 36- 39- 32(28- 85- 36) 58- 52(72) 59- 39/h32- 36,39- 51,60- 62,68- 71H,4- 28H2,1- 3H3,(H,53,67) (H,54,66) (H,55,63) (H,56,64) (H,57,65) (H2,58,59,72) /t32- ,33+,34+,35+,36- ,39- ,40+,41+,42+,43- ,44+,45+,46+,47- ,48- ,49- ,50+,51+/m0/s1 |
JJQBVPYDSQKTFY-RGMHKOGASA-N |
[C@H] 1([C@@H] ([C@H] ([C@H] ([C@H] (O1) CO) O[C@@H] 2[C@@H] ([C@H] ([C@H] ([C@H] (O2) CO) O) O) NC(C) =O) O) NC(C) =O) O[C@@H] 3[C@@H] ([C@H] ([C@H] (O[C@@H] 3CO) OCCCNC(CCOCCOCCOCCOCCOCCOCCNC(CCCC[C@H] 4[C@] 5(NC(N[C@] 5(CS4) [H] ) =O) [H] ) =O) =O) NC(C) =O) O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
View more via ChEBI Ontology
Outgoing
|
N- (3- {[α- D- GalNAc- (1→4)- α- D- GalNAc- (1→4)- α- D- GalNAc- yl]oxy}propyl)- 21- (biotinylamino)- 4,7,10,13,16,19- hexaoxadodecan- 1- amide
(CHEBI:146271)
is a
biotins
(CHEBI:51570)
N- (3- {[α- D- GalNAc- (1→4)- α- D- GalNAc- (1→4)- α- D- GalNAc- yl]oxy}propyl)- 21- (biotinylamino)- 4,7,10,13,16,19- hexaoxadodecan- 1- amide
(CHEBI:146271)
is a
trisaccharide derivative
(CHEBI:63571)
|
|
N- (3- {[2- acetamido- 2- deoxy- α- D- galactopyranosyl- (1→4)- 2- acetamido- 2- deoxy- α- D- galactopyranosyl- (1→4)- 2- acetamido- 2- deoxy- α- D- galactopyranosyl]oxy}propyl)- 23- oxo- 27- [(3aS,4S,6aR)- 2- oxohexahydro- 1H- thieno[3,4- d]imidazol- 4- yl]- 4,7,10,13,16,19- hexaoxa- 22- azaheptacosan- 1- amide
|
(3aS,4S,6aR)- N- [25- [[O- 2- (acetylamino)- 2- deoxy- α- D- galactopyranosyl- (1→4)- O- 2- (acetylamino)- 2- deoxy- α- D- galactopyranosyl- (1→4)- 2- (acetylamino)- 2- deoxy- α- D- galactopyranosyl]oxy]- 21- oxo- 3,6,9,12,15,18- hexaoxa- 22- azapentacos- 1- yl]hexahydro- 2- oxo- 1H- thieno[3,4- d]imidazole- 4- pentanamide
|
ChEBI
|
3- (21- biotinamino- 4,7,10,13,16,19- hexaoxagenicaminoamino)- propyl 2- acetamido- 2- deoxy- α- D- galactopyranosyl- (1→4)- 2- acetamido- 2- deoxy- α- D- galactopyranosyl- (1→4)- 2- acetamido- 2- deoxy- α- D- galactopyranoside
|
ChEBI
|
N- (3- {[N- acetyl- α- D- galactosaminyl- (1→4)- N- acetyl- α- D- galactosaminyl- (1→4)- N- acetyl- α- D- galactosaminyl]oxy}propyl)- 21- (biotinylamino)- 4,7,10,13,16,19- hexaoxaheptacosan- 1- amide
|
ChEBI
|
31913631
|
PubMed citation
|
Europe PMC
|
|